Rapid Dose Therapeutics Corp.
DOSE
CNSX
| 11/30/2024 | 08/31/2024 | 05/31/2024 | 02/29/2024 | 11/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -38.03% | -46.48% | -120.75% | -58.22% | -66.04% |
| Total Depreciation and Amortization | -68.72% | -65.11% | -43.80% | -36.12% | 34.66% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 691.45% | 515.44% | 4,644.55% | 290.45% | -38.18% |
| Change in Net Operating Assets | 397.46% | -9.61% | -136.80% | -124.80% | -69.25% |
| Cash from Operations | 60.69% | -38.76% | -366.97% | -1,345.26% | -459.89% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -99.19% | -89.87% | -24.59% | 412.57% |
| Total Debt Repaid | 43.45% | 89.46% | 66.93% | 46.17% | -443.66% |
| Issuance of Common Stock | -- | 1,378.47% | -- | 20,534.92% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -63.32% | -39.51% | 314.45% | 1,320.33% | 387.33% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 15.75% | -123.59% | -1,026.32% | -522.22% | -459.21% |
